Optimal measurement technology – 

uncompromising quality

VEGA - a world class measurement technology provider of level and pressure equipments now completes its measurement portfolio for pharmaceuticals production with two new compact instrument series. VEGABAR and VEGAPOINT proves that automation can be simple and highly efficient without compromising on reliability, hygiene and accuracy. 

VEGABAR 38 is a universal pressure transmitter with ceramic measuring cell for measuring gases, vapours and liquids. The optional universal connection for hygienic adapters ensures reduced installation effort and leaner stock keeping. The sensor has a display with on-site operation and coloured 360° switching status indication.

  • High plant availability through maximum overload and vacuum resistance of the ceramic measuring cell
  • Coloured 360° switching status display, display and on-site operation with VDMA menu structure
  • Easy integration into control systems through IO-Link communication

www.vega.com

VEGAPOINT 21 is a low-cost limit switch for the detection of water-based liquids. The optional universal connection for hygiene adapters ensures reduced installation effort and leaner stock keeping and perfectly meets the requirements for hygienic processes in the food, beverage and pharmaceutical industries. It can be used without adjustment in the application. With IO-Link, it offers continuous digital data transmission.

  • Coloured 360° switching status display, adjustable
  • Easy integration into control systems through IO-Link communication
  • Low-cost limit switch with smallest installation dimensions

No incompatibilities

  • VEGA sensors have been specially developed for the needs of the pharmaceutical industry, which are fulfilled by securely protected sealing, all-metal housings and wetted parts with a surface finish as fine as 0.3 µm RA.

Good manufacturing practice

  • Continuous monitoring of all production processes as well as routine inspection and testing of our sensors make us a reliable partner in adhering to good manufacturing practice. The basis for this is our quality management in compliance with ISO 9001 and our environmental management program based on ISO 14001.

Easy cleaning – reliable processes

  • To help ensure hygienic and sterile drug production processes, VEGA offers materials specially tailored to the strict requirements of the pharmaceutical industry – with all necessary approvals and material properties.

VEGA Australia Pty Ltd
Phone: +61 2 95426662
Email: info.au@vega.com

www.vega.com

Go to article: Home | Breaking the BarrierGo to article: In this issueGo to article: NSFGo to article: ContentsGo to article: AlmacGo to article: NewsGo to article: VEGA Company Insight Go to article: VEGA AustraliaGo to article: Covid-19 executive briefing by GlobalDataGo to article: Gilead’s remdesivir a candidate for US government stockpiling or bulk buying in Go to article: Covid-19’s impact on trial PROs, other endpoints can be addressed via data stratification, sensitivity analysisGo to article: ILC Dover Go to article: Vitamin D affects Covid-19 mortalityGo to article: Clinical trial disruption due to Covid-19 has begun to slowGo to article: Covid-19 boosts big bio/pharma drug sales but Regeneron may be falling shortGo to article: MimotopesGo to article: The pharma industry briefingGo to article: Charting the ups and downs of the World Health OrganizationGo to article: Road to RECOVERY: a deep dive into the world’s largest Covid-19 drug trialGo to article: Salvaging clinical trials in the time of Covid-19Go to article: Intellectual property in the time of Covid-19Go to article: Molnár-Institute Company InsightGo to article: Molnar-InstituteGo to article: A plight for sore eyes: the latest developments in seasonal allergy treatmentGo to article: How research groups are tackling the problem of biologic drug delivery Go to article: Breaking the blood-brain barrier: neurology’s greatest challengeGo to article: Timeline: charting the history of immunotherapy, cancer treatment's fourth pillarGo to article: Creating a sure data footing for AIGo to article: Koehler eClinicalGo to article: Deals in brief powered by GlobalDataGo to article: The key list powered by GlobalDataGo to article: Global markets and indices powered by GlobalDataGo to article: Macro-economic indicators (1 of 2) powered by GlobalDataGo to article: Macro-economic indicators (2 of 2) powered by GlobalDataGo to article: EventsGo to article: Next issue